TREE LendingTree, Inc.
LendingTree, Inc., through its subsidiary, operates online consumer platform in the United States. The company operates through three segments: Home, Consumer, and Insurance. The Home segments offer purchase mortgage, refinance mortgage, and home equity loans and lines of credit. The Consumer segment provides credit cards; personal, small business, and auto loans; deposit accounts; and other credit products, such as debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including automobile, home, life, and health and Medicare through which consumers are matched with insurance lead aggregators to obtain insurance offers and policies. This segment also offers QuoteWizard, a marketplace for insurance comparison; and ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is based in Charlotte, North Carolina.…
Industry Peers
Insurance BrokersKey Statistics
About LendingTree (NASDAQ: TREE)
›
LendingTree (NASDAQ: TREE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Insurance Brokers industry, part of the Financial Services sector, and reports about 919 employees.
The shares were at 34.69 USD on 19 November 2026, down 40.2% over 52 weeks. Its 52-week range is 23.50 USD to 68.93 USD: the price is 49.7% below the high and 47.6% above the low.
At a market capitalisation of 487.19M USD, it trades at 4.9 times trailing earnings and 5.1 times forward earnings. The median trailing P/E of its 17 largest Insurance Brokers peers is 24.4, a discount of 80% for TREE.
LendingTree reports return on equity of 52.8%, an operating margin of 8.3% and revenue up 11.6% year over year.
Its debt exceeds its cash by 293.12M USD, a debt-to-equity ratio of 1.53. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 50.86 USD is 46.6% above the current price. The next earnings report is expected on 1 March 2027.